Go Symbol Lookup
Loading...

U.S. Video

Unfair Ball?  Thu, 28 Mar '13 | 7:52 PM ET

Opening day of the baseball season is Monday. CNBC's Brian Shactman reports on the payroll of some of the teams. Michael Ozanian of Forbes Magazine, shares his opinions.

GOP's Pro-Growth Governors  Thu, 28 Mar '13 | 7:44 PM ET

The 10 fastest growing metro areas last year were all in red states. Art Laffer, Laffer Investments; Dean Baker, Center For Economic & Policy Research; and Hadley Heath, Independent Women's Forum, discuss.

Food Stamp Usage Up  Thu, 28 Mar '13 | 7:33 PM ET

Food stamp usage in America has gone up 70 percent since 2008. Art Laffer, Laffer Investments; Dean Baker, Center For Economic & Policy Research; and Hadley Heath, Independent Women's Forum, discuss.

Cyprus Banks Reopen  Thu, 28 Mar '13 | 7:25 PM ET

Discussing the uncertainty ahead for Cyprus, with Edward Yardeni of Yardeni Research and Michael Ozanian of Forbes Magazine.

Mad Money, March 28, 2013  Thu, 28 Mar '13 | 6:00 PM ET

Mad Money host and former hedge fund manager, Jim Cramer, provides stock traders with all manner of investing advice.

S&P; 500 & Dow Close At Record Highs  Thu, 28 Mar '13 | 7:15 PM ET

CNBC's Seema Mody takes a look at how the S&P; 500 and the Dow have performed since the lows of March in 2009; and Edward Yardeni of Yardeni Research and Michael Ozanian of Forbes Magazine, weigh in.

GOP's Secret Obamacare Plan?  Thu, 28 Mar '13 | 7:00 PM ET

Florida Republican Senator Marco Rubio has joined the filibuster threat over the pending gun control legislation, with Robert Costa of the National Review. Also, Rep. Peter Roskam (R-IL); Dean Baker Center For Economic & Policy Research; and Hadley Heath, Independent Women's Forum, discuss whether Republicans can overturn Obamacare.

Fast Money, March 28, 2013  Thu, 28 Mar '13 | 5:00 PM ET

CNBC's Melissa Lee and the Fast Money traders discuss the day's top trades and the stocks they'll be watching tomorrow.

No Huddle Offense: Hunting For a Bargain  Thu, 28 Mar '13 | 6:58 PM ET

Mad Money host Jim Cramer shares his final thoughts of the day.

Non-Executive Chairman of Avon Fred Hassan discusses his new book "Reinvent: A Leader's Playbook for Serial Success."

Lightning Round  Thu, 28 Mar '13 | 6:40 PM ET

You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.

Biotechs the Future of Pharma: Cramer  Thu, 28 Mar '13 | 6:25 PM ET

Inventing new drugs can be a fabulous growth business, but biotech stocks represent the future of pharma, explains Mad Money host Jim Cramer. A look at Regeneron Pharmaceuticals.

Vaughan Targets a Man with Dementia   Thu, 28 Mar '13 | 12:00 AM ET

F.B.I. Special Agent David Backlund tells how Doug Vaughan takes advantage of an investors¿ deteriorating mental condition to take more of his money.

Small Investment No Return  Thu, 28 Mar '13 | 12:00 AM ET

F.B.I. Special Agent David Backlund describes how Vaughan chose specific people to pay back in order to keep the fraud going.

Paychex president & CEO Marty Mucci shares his economic outlook, and discusses how his company is building customers.

Q2 Begins Monday, Cramer's Outlook  Thu, 28 Mar '13 | 6:00 PM ET

Mad Money host Jim Cramer dissects the market's latest action, and what market events to look out for in the first week of Q2.

Fast Money Final Trade  Thu, 28 Mar '13 | 5:58 PM ET

The Fast Money traders share their final trades of the day.

Emerging Market Stocks Drag In Q1  Thu, 28 Mar '13 | 5:50 PM ET

China is a major part of the weight on emerging market stocks, explains "Fast Money" trader Timothy Seymour. Also, how to play Apple now.

Options Action: Hewlett-Packard Skeptics  Thu, 28 Mar '13 | 5:45 PM ET

How options traders are playing Hewlett-Packard, with CNBC contributor Mike Khouw of CRT Capital Group LLC.

Buy Google or IBM?  Thu, 28 Mar '13 | 5:45 PM ET

In tonight's "Fast Money Madness," the traders debate whether Google or IBM make a better buy.

Q2 Defense Outlook  Thu, 28 Mar '13 | 5:40 PM ET

What to watch in the defense sector in Q2, with CNBC's Jane Wells; and how to play Home Depot and Best Buy, with the "Fast Money" traders.

Hewlett-Packard Shares Headed Even Higher?  Thu, 28 Mar '13 | 5:30 PM ET

The strongest Dow performer in Q1 is Hewlett-Packard. A closer look at the stock, with Brian Marshall, ISI Group.

Top-Performing HPQ 'Headed Down': Pro  Thu, 28 Mar '13 | 5:15 PM ET

The secular challenges for Hewlett-Packard loom large, ISI's Brian Marshall says.

BlackBerry's Wild Ride  Thu, 28 Mar '13 | 5:15 PM ET

Pinnacle Foods is up more than 11 percent in its first day of trading, with the "Fast Money" traders; and Ehud Gelblum of Morgan Stanley, shares his strategies to playing BlackBerry. "When gross margins go up in handset companies, stocks work," he says.

'Just Buy Health Care': Technician  Thu, 28 Mar '13 | 5:06 PM ET

Leaders in stock market gains by health care or consumer staples shouldn't be discounted, Chris Verrone of Strategas says.

'I Went Short' Despite S&P; High: Kelly  Thu, 28 Mar '13 | 5:00 PM ET

An all-time closing high in the S&P; 500 wasn't enough to turn Shelter Harbor Capital's Brian Kelly away from his bearish theme.

Q2 Investment Playbook  Thu, 28 Mar '13 | 5:00 PM ET

Dissecting the day's major business news, with the Fast Money traders; and Chris Verrone of Strategas, offers his strategies to playing the market. "I don't buy the argument that health care and staples are bad leadership," explains.

Tomorrow In :30  Thu, 28 Mar '13 | 4:53 PM ET

Q2 beings Monday, so which stocks should you get in? Chad Morganlander, Stifel Nicolaus; Sandy Villere, Villere & Co.; and Chad Deakins, Ridgeworth Capital Management, weigh in.

Church of Cyprus Archbishop Lawsuit  Thu, 28 Mar '13 | 4:45 PM ET

Church of Cyprus Archbishop Chrysostomos has thrown a wrench in the country's bailout deal, and is suing the head of the central bank and the minister of finance, reports CNBC's Michelle Caruso-Cabrera.

Best & Worst Sectors In Q2  Thu, 28 Mar '13 | 4:50 PM ET

Investors are looking ahead to where the money can be made in Q2. Les Funtleyder, Poliwogg health care strategist and Doug Sandler, Riverfront Investment Group, provide perspective.